找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Melatonin, Neuroprotective Agents and Antidepressant Therapy; Francisco López-Muñoz,Venkataramanujam Srinivasan, Book 2016 Springer India

[复制链接]
查看: 27981|回复: 60
发表于 2025-3-21 17:59:15 | 显示全部楼层 |阅读模式
书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy
编辑Francisco López-Muñoz,Venkataramanujam Srinivasan,
视频video
概述Detailed information on etiology of mood disorders.Provides recent thoughts on melatonin, its receptors and their role in circadian rhythms, and sleep and mood disorders.Describes therapeutic actions
图书封面Titlebook: Melatonin, Neuroprotective Agents and Antidepressant Therapy;  Francisco López-Muñoz,Venkataramanujam Srinivasan, Book 2016 Springer India
描述This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms underlying mood disorders. Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities   in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms. Many antidepressants that are in clinical use today including the recently introduced novel agentslike agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis,
出版日期Book 2016
关键词Agomelatine; Chronobiology of mood disorders; Hippocampal neurogenesis, depression and antidepressants
版次1
doihttps://doi.org/10.1007/978-81-322-2803-5
isbn_softcover978-81-322-3842-3
isbn_ebook978-81-322-2803-5
copyrightSpringer India 2016
The information of publication is updating

书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy影响因子(影响力)




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy影响因子(影响力)学科排名




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy网络公开度




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy网络公开度学科排名




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy被引频次




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy被引频次学科排名




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy年度引用




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy年度引用学科排名




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy读者反馈




书目名称Melatonin, Neuroprotective Agents and Antidepressant Therapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:49:10 | 显示全部楼层
Melatonin Induces Antidepressant-Like Behavior by Promotion of Adult Hippocampal Neurogenesis, related to adult hippocampal neurogenesis. I apologize if I failed to cite works related to the content of this chapter; however, I tried to briefly cover the most significant aspects of melatonin, hippocampal neurogenesis, and melatonin’s antidepressant-like effects.
发表于 2025-3-22 01:23:00 | 显示全部楼层
发表于 2025-3-22 06:16:19 | 显示全部楼层
发表于 2025-3-22 09:39:42 | 显示全部楼层
Melatonin as a Novel Therapeutic Agent Against Chemical Warfare Agents, low toxicity and high efficacy in reducing oxidative damage. Taking into account the multiple and beneficial properties of melatonin, the purpose of this chapter is to show its marked potential for improving human health against the most widely used CWAs.
发表于 2025-3-22 16:50:13 | 显示全部楼层
Neuropsychological Models of Depression,dresults from studies came fromdepressed versus controls, as well as the differences found in patients with melancholic and atypical depression. Finally a number of considerations are made to improve the methods of study that may be useful to better understand the psychophysiological processes of patients with depression.
发表于 2025-3-22 17:36:32 | 显示全部楼层
Melatonin Supplementation in Neurodegenerative Diseases: Current Status,), Alzheimer’s disease (AD), Huntington’s disease (HD), and amyotrophic lateral sclerosis) share the reduced capacity to maintain the balance between free radical formation and antioxidative mechanisms as a common critical factor [1].
发表于 2025-3-22 22:41:28 | 显示全部楼层
New Galenic Formulations of Melatonin,short half-life and extensive metabolism, leading to a short action when exogenous formulations are administered. For this reason, different formulations have been developed to increase and prolong the actions of melatonin.
发表于 2025-3-23 03:02:20 | 显示全部楼层
发表于 2025-3-23 05:57:50 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 17:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表